People – Page 9
-
NewsDemocratic Republic of the Congo deepens investigation on cluster of illness and community deaths in Equateur province
Health authorities in the Democratic Republic of the Congo and experts from World Health Organization (WHO) are carrying out further investigations to determine the cause of another cluster of illness and community deaths in Equateur province.
-
NewsMicrobiologist calls for urgent action on the danger of raw sewage in UK seas
A microbiologist has described how he contracted a type of bacterial pneumonia following a swim in the sea that was likely connected to an incident of sewage dumping in the area.
-
NewsNew study calls for ethical framework to protect Indigenous genetic privacy in wastewater monitoring
Researchers have called for new ethical frameworks to protect Indigenous communities’ genetic privacy in the growing field of wastewater surveillance. The study examines how analysis of community wastewater raises significant privacy concerns for Indigenous populations.
-
NewsKingdom of Saudi Arabia confirms US $500 million commitment to global polio eradication effort
The Kingdom of Saudi Arabia has reaffirmed its US $500 million pledge to the Global Polio Eradication Initiative (GPEI) in a signing event during the fourth Riyadh International Humanitarian Forum.
-
NewsAMI member Christopher Stewart named as finalist in 2025 UK Blavatnik Awards for Young Scientists
Applied Microbiology International member Dr Christopher Stewart of Newcastle University has been named as a finalist for the eighth Blavatnik Awards for Young Scientists in the UK. He is the 2023 winner of AMI’s WH Pierce Prize for microbiology.
-
NewsMass polio vaccination campaign to continue in the Gaza Strip
The emergency polio outbreak response in the Gaza Strip is continuing, with a mass vaccination campaign scheduled from 22 to 26 February 2025. The novel oral polio vaccine type 2 (nOPV2) will be administered to over 591,000 children under 10 years of age.
-
NewsProfessor awarded NSF grant to advance research on silica-scaled chrysophytes
A new National Science Foundation (NSF) grant will support a major effort to synthesize decades of research on protists. The project will integrate findings from Professor Peter Siver’s lifelong study of silica-scaled chrysophytes, a group of protists found in freshwater environments.
-
NewsScientists to forecast climate tipping points by capturing ocean’s pulse - plankton
A new project is set to revolutionise climate forecasting by focusing on plankton as the “canaries in the coalmine” of ocean health. Next-generation autonomous underwater robots will deliver near real-time observations in the North Atlantic subpolar gyre.
-
NewsProfessor Cristobal Uauy appointed as Director of the John Innes Centre
Following an international search, Professor Cristóbal Uauy has been appointed as the next Director of the John Innes Centre.
-
NewsResearchers explore Spanish flu’s impact on Appalachia
A new book examines how the 1918 influenza pandemic disproportionately impacted Appalachian communities, exacerbating long-standing health disparities. Those included limited health care access, poor working conditions and systemic poverty.
-
NewsInternational team publishes guideline on how to manage fungal infections caused by Candida
The new global guideline for the diagnosis and treatment of Candida infections establishes new standards for managing fungal infections, which affect millions of people worldwide every year.
-
NewsHarvard Pilgrim Health Care Institute announces launch of Center for Sepsis Epidemiology and Prevention Studies (SEPSIS)
The new Center for Sepsis Epidemiology and Prevention Studies (SEPSIS) is a pioneering center of excellence dedicated to advancing understanding, prevention, and management of sepsis, a life-threatening condition caused by a dysregulated immune response to infection.
-
-
NewsNasal COVID-19 vaccine to enter US clinical trials
A nasal vaccine for COVID-19 is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug application from Ocugen, Inc. was approved by the Food and Drug Administration (FDA).
-
NewsNIH awards $20.6 million grant to establish Human Virome Characterization Center at UCLA
NIH has awarded a $20.6 million grant over five years to establish one of five Human Virome Characterization Centers to advance understanding of the virome’s role in human health and disease across the oral-gut-brain axis.
-
NewsHow worried should we be about bird flu? An expert explains.
As U.S. health officials announce that a new strain of avian flu, H5N9, has been discovered on a duck farm in California, UC Berkeley School of Public Health’s John Swartzberg opens up on how much of a threat it poses.
-
NewsGroundbreaking Ebola vaccination trial launches in Uganda
In a global first, Uganda’s Ministry of Health, the World Health Organization (WHO) and other partners have launched a first ever vaccine trial for Ebola from the Sudan species of the virus, and at an unprecedented speed for a randomized vaccine trial in an emergency. Source: CDC Global ...
-
NewsUrgent action needed to keep Europe polio-free, warn heads of ECDC and WHO Europe
An unusually high amount of poliovirus detections in several European countries in recent months has underscored the importance of keeping Europe polio-free.
-
NewsScientists probe honeybee antiviral defense mechanisms
Scientists are investigating honeybee antiviral defense mechanisms with the goal of developing strategies to reduce honeybee colony deaths.
-
NewsNIH-funded clinical trial will evaluate new dengue therapeutic
A clinical trial is testing an experimental treatment designed to help people suffering the effects of dengue. An investigational therapeutic will be administered to adult volunteers who have been exposed to a weakened strain that causes a mild form of the disease.